Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, and its vertically integrated commercial model is reshaping the delivery of prescription therapies. Cala Health’s lead product, Cala Trio™, is the only non-invasive prescription therapy for essential tremor. New therapies are under development in neurology, cardiology and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
In The News
Electricity as Medicine: Lux Capital's Josh Wolfe and Cala Health CEO Renee Ryan
Cala Health named A GOLD WINNER of the 2020 Edison Awards
Cala Health Applauded by Frost & Sullivan for Revolutionizing the Essential Tremor Market with its Body-worn Neuromodulation Therapy, Cala Trio™
Meet the Team
Join the Team
Cala Health believes our success is based on diversity of people, teams and thinking. We offer all employees the tools, training and mentoring they need to succeed. Our selection process is driven by the key requirements for the role rather than bias or discrimination on the basis of a candidate’s sex, gender identity, age, marital status, veteran status, non-job-related disability/handicap or medical condition, family status, sexual orientation, religion, color, ethnicity, race or any other legally protected classification.
Building a new category of therapies requires breakthrough thinking. Intense curiosity drives us to discover and design life-changing solutions.
Talented people thrive in passionate, inclusive teams where every team member matters. We inspire each other to make the impossible possible.
Building the Future
We are delivering innovative therapies at the cutting-edge of technology and neuroscience. We believe non-invasive electrical medicines will change the face of healthcare.